Application of a Physiologically-based Pharmacokinetic/Pharmacodynamic (PBPK/PD) Model to Investigate the Effect of OATP1B1 Genotypes on the Cholesterol Synthesis Inhibitory Effect of Rosuvastatin

Author(s): R. H. Rose, S. Neuhoff, K. Abduljalil, M. Chetty, M. Jamei, A. Rostami-Hodjegan
Year:

Learn More
LinkedIn